Search

Page Title

Clinical Trial Finder

You can help advance cystic fibrosis research — starting now.

Tailor your search using the filters on the left.
Need help? Watch  a video tutorial or contact the Clinical Trial Navigator, a real person who can assist you.

Clear search

Filter

Tailor your results by using the filters below.

Tailor your search using the filters on the left.
Need help? Watch  a video tutorial or contact the Clinical Trial Navigator, a real person who can assist you.

Showing 1-1 of 1 studies

  • Mucociliary ClearanceCompleted with Results

    Phase 1b study of inhaled AZD5634 in adults with CF , protocol number AstraZeneca D6600C00002

    This study evaluated the safety and tolerability of the inhaled drug AZD5634 in people with CF. It also evaluated the effect of AZD5634 on improving the ability to clear mucus from the lungs (lung mucociliary clearance - MCC).

    • Age:

      18 Years to 60 Years

    • Mutation(s):

      No Mutation Requirement

    • FEV1% Predicted:

      40% or greater

    • Number of Visits:

      4

    • Length of Participation:

      4 months

Showing 1-1 of 1 studies

Studies in this tool are multi-center studies facilitated by the Cystic Fibrosis Therapeutics Development Network. For a complete list of cystic fibrosis related studies, visit www.clinicaltrials.gov.

CONTACT THE CLINICAL TRIAL NAVIGATOR

Get personalized assistance and answers to your clinical trial questions.

Learn More

Sign up for clinical trial alerts

Get email updates about clinical trials that matter to you.

Check the Drug Development Pipeline

We’re attacking CF from every angle. Learn about the status of CF drugs in development.

Learn More